PLoS ONE (Jan 2013)

The transcriptional co-regulator HCF-1 is required for INS-1 β-cell glucose-stimulated insulin secretion.

  • Terri N Iwata,
  • Timothy J Cowley,
  • Michael Sloma,
  • Yewei Ji,
  • Hana Kim,
  • Ling Qi,
  • Siu Sylvia Lee

DOI
https://doi.org/10.1371/journal.pone.0078841
Journal volume & issue
Vol. 8, no. 11
p. e78841

Abstract

Read online

The transcriptional co-regulator host cell factor-1 (HCF-1) plays critical roles in promoting cell cycle progression in diverse cell types, and in maintaining self-renewal of embryonic stem cells, but its role in pancreatic β-cell function has not been investigated. Immunhistochemistry of mouse pancreas revealed nuclear expression of HCF-1 in pancreatic islets. Reducing HCF-1 expression in the INS-1 pancreatic β-cell line resulted in reduced cell proliferation, reduced glucose-stimulated insulin secretion, and reduced expression of the critical β-cell transcription factor Pdx1. HCF-1 is a known co-activator of the E2F1 transcription factor, and loss of E2F1 results in pancreatic β-cell dysfunction and reduced expression of Pdx1. Therefore we wondered whether HCF-1 might be required for E2F1 regulation of Pdx1. Chromatin immunoprecipitation experiments revealed that HCF-1 and E2F1 co-localize to the Pdx1 promoter. These results indicate that HCF-1 represents a novel transcriptional regulator required for maintaining pancreatic β-cell function.